Bálint, B., Wéber, C., Cruzalegui, F., Burbridge, M., Kotschy, A., 2017. Structure-Based Design and Synthesis of Harmine Derivatives with Different Selectivity Profiles in Kinase versus Monoamine Oxidase Inhibition. ChemMedChem 12, 932–939.
Clarke, S.E.D., Ramsay, R.R., 2011. Dietary inhibitors of monoamine oxidase A. Journal of Neural Transmission 118, 1031–1041.
Herraiz, T., Brandt, S.D., 2014. 5-(2-Aminopropyl) indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO). Drug testing and analysis 6, 607–613.
Herraiz, T., Chaparro, C., 2005. Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors. Biochemical and biophysical research communications 326, 378–386.
Ionescu, A., Dufrasne, F., Gelbcke, M., Jabin, I., Kiss, R., Lamoral-Theys, D., 2012. DYRK1A kinase inhibitors with emphasis on cancer. Mini reviews in medicinal chemistry 12, 1315–1329.
Kim, H., Sablin, S.O., Ramsay, R.R., 1997. Inhibition of monoamine oxidase A by betacarboline derivatives. Arch Biochem Biophys 337, 137–142.
Rahman, T., Rahmatullah, M., 2010. Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Bioorganic & medicinal chemistry letters 20, 537–540.
Reniers, J., Robert, S., Frederick, R., Masereel, B., Vincent, S., Wouters, J., 2011. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors. Bioorganic & medicinal chemistry 19, 134–144.
Rommelspacher, H., May, T., Salewski, B., 1994. Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats. European journal of pharmacology 252, 51–59.
Rüben, K., Wurzlbauer, A., Walte, A., Sippl, W., Bracher, F., Becker, W., 2015. Selectivity profiling and biological activity of novel β-carbolines as potent and selective DYRK1 kinase inhibitors. PloS one 10, e0132453.
Santillo, M.F., Liu, Y., Ferguson, M., Vohra, S.N., Wiesenfeld, P.L., 2014. Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells. Toxicology in Vitro 28, 403–410.
Wurzlbauer, A., Rüben, K., Gürdal, E., Chaikuad, A., Knapp, S., Sippl, W., Becker, W., Bracher, F., 2020. How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine. Molecules 25, 5962.